References
- Wildt L, Diedrich K, van der Ven H, Hasani S, Hubner H, Klasen R. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotropins. Hum Reprod 1986; 1: 15–9
- MacLachlan V, Besanko M, O'Shea F, et al. A controlled study of luteinizing hormone-releasing hormone agonist (Buserelin) for the induction of folliculogenesis before in vitro fertilization. N Engl J Med 1989; 320: 1233–7
- Meldrum D R, Wisot A, Hamilton F, Gutlay A L, Huynh D, Kempton W. Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil Steril 1988; 50: 400–2
- Hoist N, Bertheussen K, Forsdahl F, Berger Hakonsen M, Jul Hansen L, Nielsen H I. Optimization and simplification of culture conditions in human in vitro fertilization and pre-embryo replacement by serum-free media. J Virto Fert Embryo Transfer 1990; 7: 47–53
- Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs R P. An alternate approach to controlled ovarian hyperstimulation in 'poor responders': pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988; 49: 90–5
- Belaisch-Allart J, Testart J, Frydman R. Utilization of GnRH agonists for poor responders in an IVF programme. Hum Reprod 1989; 4: 33–4
- Crosignani P G, Ragni G, Lombroso G C, et al. Ovarian stimulation of IVF patients: effects of the reversible hypogonadotrophic state induced by GnRH agonist. Hum Reprod 1988; 3(Suppl 2)39–41
- Cameron I T, O'Shea F C, Rolland J M, Hughes E G, de Kretser D M, Healy D L. Occult ovarian failure: A syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 1988; 67: 1190–4
- Howies C M, Macnamee M C, Edwards R G. Short-term use of an LHRH agonist to treat poor responders entering an in vitro fertilization (IVF) programme. Hum Reprod 1987; 2: 655–6